Aclaris Therapeutics, Inc. Quarterly Current Ratio in % from Q2 2016 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Aclaris Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q2 2016 to Q3 2024.
  • Aclaris Therapeutics, Inc. Current Ratio for the quarter ending September 30, 2024 was 601 %, a 19.2% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 601 -143 -19.2% Sep 30, 2024
Q2 2024 537 -436 -44.8% Jun 30, 2024
Q1 2024 514 -709 -58% Mar 31, 2024
Q4 2023 573 -684 -54.4% Dec 31, 2023
Q3 2023 744 -461 -38.3% Sep 30, 2023
Q2 2023 973 -196 -16.7% Jun 30, 2023
Q1 2023 1.22K +58.7 +5.05% Mar 31, 2023
Q4 2022 1.26K +136 +12.1% Dec 31, 2022
Q3 2022 1.21K +177 +17.2% Sep 30, 2022
Q2 2022 1.17K +308 +35.7% Jun 30, 2022
Q1 2022 1.16K +628 +117% Mar 31, 2022
Q4 2021 1.12K +713 +175% Dec 31, 2021
Q3 2021 1.03K +627 +156% Sep 30, 2021
Q2 2021 861 +477 +124% Jun 30, 2021
Q1 2021 536 +175 +48.6% Mar 31, 2021
Q4 2020 408 +34.6 +9.28% Dec 31, 2020
Q3 2020 402 -24.8 -5.81% Sep 30, 2020
Q2 2020 384 -98.2 -20.4% Jun 30, 2020
Q1 2020 360 -256 -41.5% Mar 31, 2020
Q4 2019 373 -451 -54.7% Dec 31, 2019
Q3 2019 426 -602 -58.6% Sep 30, 2019
Q2 2019 482 -926 -65.8% Jun 30, 2019
Q1 2019 617 -1.17K -65.5% Mar 31, 2019
Q4 2018 824 -1.26K -60.5% Dec 31, 2018
Q3 2018 1.03K -1.31K -55.9% Sep 30, 2018
Q2 2018 1.41K -837 -37.3% Jun 30, 2018
Q1 2018 1.79K -388 -17.8% Mar 31, 2018
Q4 2017 2.09K +59.6 +2.94% Dec 31, 2017
Q3 2017 2.34K +30.1 +1.31% Sep 30, 2017
Q2 2017 2.25K -185 -7.62% Jun 30, 2017
Q1 2017 2.17K Mar 31, 2017
Q4 2016 2.03K Dec 31, 2016
Q3 2016 2.31K Sep 30, 2016
Q2 2016 2.43K Jun 30, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.